For the Inventor, By the Inventor

Enter assignee name

Dusseldorf, Germany

Coley Pharmaceutical Gmbh

USPTO Granted Patents = 27

CIPO Patents = 3

EPO Patents = 7

Forward Citations = 932

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Jörg Vollmer (16 out of 16 patents)

Arthur Mertz Krieg (13 out of 68 patents)

Eugen Uhlmann (11 out of 80 patents)

4. Marion Jurk (9 out of 10 patents)

5. Grayson B Lipford (7 out of 23 patents)

6. Ulrike Samulowitz (5 out of 5 patents)

7. Gunther Hartmann (3 out of 19 patents)

8. Harald Debelak (3 out of 6 patents)

9. Hermann Wagner (3 out of 10 patents)

10. Alexandra Forsbach (3 out of 3 patents)

11. Stefan Bauer (2 out of 24 patents)

12. Heather Lynn Davis (2 out of 16 patents)

13. Robert L Bratzler (2 out of 6 patents)

14. Robert Rankin (2 out of 2 patents)

15. Charles M Zepp (1 out of 57 patents)

27 patents: Sort by Forward Citations

1. 10260071 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2019-04-16),

2. 9382545 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2016-07-05),

3. 8834900 - Combination motif immune stimulatory oligonucleotides with improved activity (2014-09-16),

4. 8580268 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2013-11-12),

5. 8466124 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2013-06-18),

6. 8354522 - Immunostimulatory oligoribonucleotides (2013-01-15),

7. 8304396 - Immunostimulatory nucleic acids (2012-11-06),

8. 8283328 - Immunostimulatory nucleic acids (2012-10-09),

9. 8227447 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2012-07-24),

10. 8202688 - Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant (2012-06-19),

11. 8198251 - Combination motif immune stimulatory oligonucleotides with improved activity (2012-06-12),

12. 8188254 - C-class oligonucleotide analogs with enhanced immunostimulatory potency (2012-05-29),

13. 8153141 - Immunostimulatory G, U-containing oligoribonucleotides (2012-04-10),

14. 8128944 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2012-03-06),

15. 7998492 - Methods and products related to treatment and prevention of hepatitis C virus infection (2011-08-16),

Coley Pharmaceutical GmbH is a leading biopharmaceutical company specializing in the development and commercialization of innovative immunotherapy products. With a focus on targeted cancer treatments, we strive to revolutionize cancer therapy by harnessing the power of the immune system. Our team of experienced researchers and scientists work diligently to create novel immunotherapy solutions that can improve patient outcomes. Visit our website to learn more about our groundbreaking research and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

27 Patents

#11 in Dusseldorf

#1,768 in Germany

#23,293 in the World

Dusseldorf, Germany

Coley Pharmaceutical Gmbh

Forward Citations = 932

24 inventors:

Jörg Vollmer (16 out of 16 patents)

Arthur Mertz Krieg (13 out of 68 patents)

Eugen Uhlmann (11 out of 80 patents)

4. Marion Jurk (9 out of 10 patents)

5. Grayson B Lipford (7 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…